Janus Henderson Group
TENX icon

Janus Henderson Group’s Tenax Therapeutics TENX Stock Holding History

Janus Henderson Group’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$29.1M Buy
1,815,474
+1,648,808
+989% +$22.3M 0.01% 521
2025
Q4 		$2.02M Hold
166,666
– – ﹤0.01% 1327
2025
Q3 		$1.27M Hold
166,666
– – ﹤0.01% 1533
2025
Q2 		$978K Hold
166,666
– – ﹤0.01% 1626
2025
Q1 		$1.06M Hold
166,666
– – ﹤0.01% 1594
2024
Q4 		$1.03M Buy
+166,666
New +$809K ﹤0.01% 1671

Other funds holding TENX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Janus Henderson Group's TENX Position: Q1 2026 in Review

Janus Henderson Group increased its Tenax Therapeutics (TENX) stake by 989% in Q1 2026, buying an estimated $22.3M and bringing the position to 1,815,474 shares worth $29.1M. The position accounts for 0.01% of the portfolio, ranked #521.

Janus Henderson Group first reported a position in TENX in Q4 2024 and has held it in 6 quarters since. 80 funds tracked by Wall St. Rank hold TENX as of Q1 2026.

  • Janus Henderson Group held 1,815,474 shares of Tenax Therapeutics worth $29.1M as of Q1 2026.
  • Janus Henderson Group bought 1,648,808 Tenax Therapeutics shares in Q1 2026, an estimated $22.3M.
  • Tenax Therapeutics made up 0.01% of Janus Henderson Group's portfolio in Q1 2026, its #521 holding.
  • Janus Henderson Group first reported a position in Tenax Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • 80 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.